ScPharmaceuticals Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Kronos Bio (KRON), Spruce Biosciences (SPRB) and ScPharmaceuticals (SCPH)
H.C. Wainwright Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Maintains Target Price $18
Maxim Group Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Maintains Target Price $20
Buy Rating Affirmed: ScPharmaceuticals's Revenue Surge and Product Development Promise
Craig-Hallum Maintains ScPharmaceuticals(SCPH.US) With Buy Rating
TD Cowen Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Maintains Target Price $25
Craig-Hallum Maintains ScPharmaceuticals(SCPH.US) With Buy Rating
Craig-Hallum Maintains ScPharmaceuticals(SCPH.US) With Buy Rating
Leerink Partners Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Cuts Target Price to $20
Buy Rating Affirmed for ScPharmaceuticals Amidst FDA Approval and Strong Financial Performance
Craig-Hallum Maintains ScPharmaceuticals(SCPH.US) With Buy Rating
TD Cowen Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Maintains Target Price $25
TD Cowen Sticks to Its Buy Rating for ScPharmaceuticals (SCPH)
Craig-Hallum Maintains ScPharmaceuticals(SCPH.US) With Buy Rating
Craig-Hallum Releases a Buy Rating on ScPharmaceuticals (SCPH)
Analysts Have Conflicting Sentiments on These Healthcare Companies: ScPharmaceuticals (SCPH), Andlauer Healthcare Group (OtherANDHF) and Roche Holding AG (OtherRHHVF)
Furoscix Growth Prospects Anchor Buy Rating for ScPharmaceuticals
Analysts Are Bullish on These Healthcare Stocks: ScPharmaceuticals (SCPH), Optinose (OPTN)
ScPharmaceuticals Analyst Ratings
No Data
No Data